A medication used to treat adults with type 2 diabetes mellitus (non-insulin-dependent diabetes) whose blood sugar can no longer be controlled satisfactorily by diet, weight reduction, and exercise alone. This medicine works by helping the pancreas release more insulin at mealtimes, lowering blood glucose levels, and improving glycemic control.
Indications:
- Regulates blood sugar levels in type 2 diabetes patients.
- Reduces the risk of diabetic complications such as nerve, kidney, and eye damage.
- Enhances the effectiveness of diet and exercise in glucose control.
Main Active Ingredient:
- Repaglinide 0.5 mg.
Precautions:
- May increase the risk of hypoglycemia, especially if meals are skipped or delayed.
- Use with caution in patients with kidney or liver impairment.
- Not recommended for individuals under 18 or over 75 years of age without specialist advice.
Side Effects:
- Low blood sugar (hypoglycemia).
- Abdominal pain, diarrhea, constipation, or nausea.
- Headache or allergic skin reactions.
Drug–Drug Interactions:
- Clarithromycin: increases the effects of repaglinide.
- Beta-blockers: may mask warning signs of hypoglycemia.
- Other antidiabetic medications: may enhance blood sugar-lowering effects.
- Take NovoNorm as directed by your doctor, usually within 30 minutes before each main meal—repeat for 2 to 4 meals daily.
- If you skip a meal, skip that dose as well.
- Always monitor your blood glucose regularly.
Repaglinide, Microcrystalline Cellulose (E460), Calcium Hydrogen Phosphate Anhydrous, Maize Starch, Polacrilin Potassium, Povidone (Polyvidone), Glycerol 85%, Magnesium Stearate, Meglumine, Poloxamer, Iron Oxide Yellow (E172) Only In The 1 mg Tablets, and Iron Oxide Red (E172) Only In The 2 mg Tablets.
Repaglinide
